Our Mission

The Ataxia Charlevoix-Saguenay Foundation’s mission is to discover and develop a treatment for the Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

The Ataxia Charlevoix-Saguenay Foundation is a federally registered charity established in 2006. The Foundation is supported entirely by private donations and volunteers to fund scientific research on ARSACS. 

What We Do

RAISE FUNDS

The Ataxia Charlevoix-Saguenay Foundation is a charitable organization supported entirely by private donations. Different events are organized during the year by families, friends and community groups to raise funds to support research on ARSACS.

SPEND ON RESEARCH

The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS. Several research projects on ARSACS are currently funded by the Foundation in Canada and abroad. 

PRECLINICAL AND CLINICAL TRIALS

The Foundation is ready to conduct preclinical and clinical trials. It has the expertise and the tools available. Furthermore, the existing ARSACS International Patient Registry is a good source of potential patients interested in participating in such trials.

ASSEMBLE A GREAT TEAM

Since its creation, the Foundation has been successful in assembling a great team at all levels of the organization (board, advisors, researchers, contributors and partners). The researchers are well respected in their field and have an international reputation for excellence.

DISCOVER

The main research objective of the Ataxia Charlevoix-Saguenay Foundation is to develop a treatment for ARSACS.

Researchers

The Ataxia Charlevoix-Saguenay Foundation research team is composed of many researchers around the world. The researchers are well respected in their field and have an international reputation for their expertise.

Every year, the Foundation finances several ARSACS research projects.

OUR TEAM

Founders

The Ataxia Charlevoix-Saguenay Foundation was founded in 2006 

" Our journey began as concerned parents driven by the belief that every child deserves hope and a future free from this rare disease ARSACS.  We are committed tiressely pursuing research and breakthroughs fuelled by the hope of finding a treatment that will improve the lives of not only our children by all those affected by this condition".

Jean Groleau
Co-founder
Sonia Gobeil
Co-founder

Board of Directors

Dr. Paolo Arrigoni
Specialist in Orthopedics, University of Milan, Italy
Carl Deslongchamps
Canadian Tax Foundation
Dr. Luc Desnoyers
Vice- President of Neuron23
Julie Duchesne
Business Leader at Mercer
Dr. Nicolas Dupré
Centre Hospitalier Affilié Universitaire de Québec
Dr. Martin Godbout
President of Hodran Inc.
Catherine Groleau
Portfolio manager at RBC Dominion Securities
Jean Groleau
Co-founder
Robert Guy
President of Groupe RSM Capital, Desjardins Group
Jacques Marchand
President of Briva Finances
Dr. Massimo Pandolfo
Professor of Neurology, McGill University
Dr. Marc Rivière
General Partner at TVM Life Management Science
Dr. Guy A. Rouleau
Director of the NEURO
Betsy Trainor
Corporate Attorney at Fibertek

Researchers

The Ataxia Charlevoix-Saguenay Foundation research team is composed of many researchers around the world. The researchers are well respected in their field and have an international reputation for their expertise.

Every year, the Foundation finances several ARSACS research projects.